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Executive Summary 
Background 
Female genital mutilation/cutting (FGM/C) is a cultural practice associated with health 
consequences, women/girls rights abuse, and violation. The health sector is well positioned to 
respond to FGM/C through prevention and care interventions for women and girls living with 
complications. The Kenyan health sector–led FGM/C-related interventions are anchored in the 
legal and policy instruments and guidelines adapted from global/regional frameworks, as well as 
interventional tools approved by the World Health Organization (WHO). Despite the existence of 
the instruments, guidelines, and tools that should direct a robust health system’s response to 
FGM/C, the practice persists while the quality-of-care services for the women and girls with 
FGM/C-related complications has not been ascertained. Evidence on whether the health sector 
implements relevant FGM/C-related legal and policy frameworks to address the practice and its 
related impacts is also lacking. To address these gaps, we conducted a diagnostic assessment of 
the health sector’s response to FGM/C management and prevention, with a view to identifying 
possible solutions to strengthen it to contribute to the abandonment of FGM/C. We selected West 
Pokot County, which borders Uganda, as the primary study site because of the high prevalence of 
FGM/C among the Pokot, who predominantly practise infibulation—a practice associated with an 
increased risk of health complications. West Pokot is also a target county for the UNFPA-UNICEF 
Joint Programme on Female Genital Mutilation/Cutting: Accelerating Change. 
Methods 
We conducted a mixed-method study involving qualitative and quantitative data collection at 
national, county, and health-facility levels. We conducted (1) key informant interviews (KIIs) with 
FGM/C policy actors at national and county levels; (2) focus group discussions (FGDs) with service 
providers; (3) in-depth interviews (IDIs) with service providers; (4) health facility assessments; (5) 
observations of client–provider interactions; (6) client exit interviews; and (7) service data 
abstraction. The participants included national and county actors involved in policy formulation 
from the government (relevant ministries, departments, and agencies), health-related development 
partners, nongovernmental organisations (NGOs), health professional regulatory organisations 
and associations, and training institutions. We also interviewed doctors, nurses/midwives, and 
clinical officers working in West Pokot health facility service delivery points, as well as girls (14–17 
years) and women (18 years and older) seeking care for FGM/C-related complications. Qualitative 
data were transcribed and analysed using a framework method template, while quantitative data 
were descriptively analysed. Ethical approvals were granted by the AMREF Ethics and Research 
Committee and the Population Council Institutional Review Board. The administrative approvals 
were granted by the National Commission for Science, Technology and Innovation (NACOSTI), 
the West Pokot County Commissioner, and the Director of Health Services in West Pokot.  
Results 
We conducted four FGDs, 23 IDIs, 34 KIIs, 360 exit interviews, 61 client–provider interactions, 30 
health facility assessments, and service data abstraction from 10 facilities. We outline the key study 
findings below. 
There were variations in awareness or knowledge of laws and policies that address FGM/C-
related prevention and management. Some national- and county-level actors identified various 
health sector–relevant laws addressing prevention and management of FGM/C. The laws included 
the Constitution of Kenya 2010, which guarantees fundamental rights; the Prohibition of FGM Act 
of 2011, which criminalises and prescribes fines/punishment for cutting; the Children Act of 2001, 
which prohibits FGM/C among those younger than 18 years; and the Protection against Domestic 
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Violence Act of 2015, which considers FGM/C a form of violence. The development and review of 
FGM/C-related laws were linked to the adoption of global or regional instruments and triggered by 
FGM/C-related health consequences, poor maternal indicators, social economic impacts (e.g., low 
education attainment or school dropouts), adoption of the Sustainable Development Goals, the 
need to address human rights violations, as well as a high FGM/C burden.  
Most national actors highlighted various FGM/C-related policies relevant to the health sector 
including the National Adolescent Sexual and Reproductive Health Policy. At the county level, 
participants made reference to the national School Health Policy. These policies were noted to 
lack details on the prevention of medicalisation and the management of FGM/C-related 
complications. A lack of guidelines that addressed management and prevention of FGM/C was 
also noted to lead to a generic approach to interventions just like other medical/surgical cases.  
The service data abstraction and health facility assessments showed that there was limited or 
inconsistent documentation of FGM/C-related cases and complications in the service 
delivery points. For example, although participants noted that women and girls presented to 
health facilities with bleeding and infections related to FGM/C, there were no data supporting the 
information. Furthermore, data on those who sought care for FGM/C-related complications were 
lacking. The lack of data was attributed to the absence of a policy framework providing for the 
availability of FGM/C-related data-capture tools at the service points. Although data on 
reproductive health services were available, data on women and girls with FGM/C and/or related 
complications who sought antenatal, postnatal, family planning, and youth-friendly services were 
lacking.  
Although West Pokot County had adequate health infrastructural and human capacity to conduct 
preventive interventions for priority programmes, only minimal unstructured FGM/C prevention 
interventions were implemented. These included counselling of clients with FGM/C on the 
practice, its attendant complications, and the need to protect daughters from cutting. Although the 
client interviews showed there were explanations (99%) and instructions (89%) for treatments to 
clients, most providers (84%) did not explain the negative consequences of FGM/C or discuss the 
need to stop practising FGM/C. Most providers did not identify or enquire about FGM/C status, its 
severity, and possible FGM/C-related effects, nor did they inform clients of findings from their 
physical examination.  
The health sector leveraged on school health, community outreach, community volunteer-
led,, and vernacular radio shows to create FGM/C awareness. Facility-linked health talks on 
FGM/C by health providers were reported, but only 23% of health facilities shared information on 
or discussed FGM/C, while approximately 70% health facilities failed to educate or advise clients 
on FGM/C. Some community health volunteer–led FGM/C prevention and vernacular radio FGM/C 
messaging were implemented. Another approach involved motivating pregnant women and 
incentivising traditional birth attendants to address FGM/C and poor birth outcomes. These 
interventions were, however, hampered by the lack of guidelines and protocols; information, 
education, and communication (IEC) resources; inadequate capacity of healthcare providers; and 
limited funding. 
We found that women and girls presented with a wide range of complications including 
sexual and psychological complications. Women were reported to present with birth 
complications including tears on the external genitalia, and postpartum haemorrhage prompting 
episiotomies, and caesarean section. Long-term complications included fistulas, scars, and 
keloids, while psychological impacts included psychological trauma and stigmatisation. Women 
were noted to present with FGM/C-related sexual complications characterised by difficulty in 
penetration, painful intercourse, and lack of enjoyment.  
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Although some clients received treatment in the first health facility they presented to, many women 
and girls were referred to higher-level facilities because providers lacked the capacity to 
address these complications. The referrals for women with FGM/C-related birth complications 
to higher-level facilities existed in 63% of facilities. The FGM/C-related referrals included birth 
complications (48%), gynaecological (32%) and immediate (11%) complications. 
Although women/girls were noted to present with FGM/C-related complications, there were 
no specific interventions prescribed in the guidelines and protocols to address them. 
Instead the complications were generally managed symptomatically. Noteworthy were the 
challenges performing de-infibulation to address FGM/C-related birth complications because of 
limited capacity resulting in many of these complications being managed through episiotomies and 
caesarean sections. We found no evidence of interventions implemented to mitigate sexual and 
psychological complications.  
Conclusion 
The Kenyan health-sector response to FGM/C prevention and management is anchored in legal 
and policy instruments adopted from global and regional frameworks. Although the instruments 
are well understood by policy actors at the national and county level, few healthcare providers 
appear to be aware of these instruments. This limited awareness has a negative impact on the 
quality of care received by women and girls and curtails the involvement of health system actors 
in prevention efforts. Further, the health system lacks procedures to document and capture data 
related to FGM/C cases or complications, which may limit programming and investments targeted 
to the prevention and management of the practice. These findings underscore the need for 
investments to strengthen the health sector’s response to FGM/C by developing appropriate 
FGM/C-related tools and guidelines that inform the prevention, management, and quality of care 
for women with FGM/C, including integration of interventions at all levels of the health sector.  
Implications for policy/programmes/research 
The study findings highlight several possible avenues for leveraging positive change: 
• Stakeholders in different levels of the health system should be sensitised about laws and 
policies that address FGM/C prevention and management. 
• Tools to guide and support FGM/C-related prevention and management interventions should 
be developed.  
• Healthcare providers should be adequately trained to respond to women and girls with FGM/C-
related complications including birth, sexual, and psychological factors. 
• Systems to collect and document data on FGM/C in health facilities should be developed for 
use in policy, programming, and investment decision-making. 
• The referral system for FGM/C-related complications should be strengthened. 
• The health system should be adequately integrated and financed to respond to prevention and 
management of FGM/C. 
• A cost-utility analysis to examine the financial implication of integration of FGM/C interventions 
into the health services is needed.  
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Introduction  
The practice of female genital mutilation/cutting (FGM/C) undermines women’s and girls’ rights, 
health, and full realisation of their potential. The practice involves partial or total removal of the 
female external genitalia or other injuries to the female genital organs for nonmedical reasons 
(WHO 2008, 2016). The World Health Organisation (WHO) categorises the practice into four types: 
type I—partial or total removal of the clitoris and/or the prepuce (clitoridectomy); type II - partial or 
total removal of the clitoris and the labia minora, with or without excision of the labia majora 
(excision); type III—narrowing of the vaginal orifice with creation of a covering seal by cutting and 
appositioning the labia minora and/or the labia majora, with or without excision of the clitoris 
(infibulation); and type IV—all other harmful procedures to the female genitalia for nonmedical 
purposes, including pricking, piercing, incising, scraping and cauterisation (WHO 2016). 
Despite the practice of FGM/C being culturally entrenched, it also spreads with migration of the 
practising communities. Globally, over 200 million women and girls are cut and living with FGM/C-
related consequences (UNICEF 2016), while 3.6 million girls are at risk of undergoing cutting each 
year (UNICEF 2016). The greatest magnitude and the risk for FGM/C are disproportionally borne 
across different ethnic groups in 28 African countries (mainly in East, North East, and West Africa), 
pockets in Asia, the Middle East, Latin America, and in North America, Europe, Australia, and New 
Zealand among migrant practising populations (UNICEF 2016; Yoder, Wang, and Johansen 2013). 
In Kenya, FGM/C is traditionally practised by all but five ethnic groups. In 2014, the national 
prevalence among women and girls aged 15–49 years was 21%, spanning from a high of 94% in 
the North Eastern counties to a low of 1% in Western Kenyan, depending on the ethnic and 
geographical determinants relevant to the practice (KDHS 2014). Further, there is evidence of 
increasing medicalisation (performance of FGM/C by health professionals) and in 2014, about one 
in five (19.7%) cut girls had been cut by a health professional (KDHS 2014), with the prevalence 
of medicalisation varying by ethnicity, geographic location, and education among other factors 
(KDHS 2014). 
There are no health benefits associated with FGM/C; instead it has undesirable consequences on 
health (physical, psychological, sexual) and social well-being (Chibber, El-Saleh, and El Harmi 
2011; Kimani, Muteshi, and Njue 2016; Vloeberghs et al. 2012; WHO 2006). High rates of maternal 
and infant morbidity and mortality are common among communities that practise FGM/C (WHO 
2006). The health harms associated with FGM/C can be immediate, short- and/or long-term (Berg 
et al. 2016; Kaplan et al. 2011; WHO 2006). Complications include severe bleeding, urine and 
menstrual retention, cysts, infections (including genital, reproductive, and urinary tract infections, 
and HIV), painful intercourse, and even death (Berg and Underland 2013; Bjälkander et al. 2012; 
Kimani, Muteshi, and Njue 2016; Njue and Askew 2004). Psychologically, women and girls who 
have undergone FGM/C have been reported to struggle with anxiety, depression, post-traumatic 
stress disorder, and low self-esteem (Behrendt and Moritz 2005; Whitehorn, Ayonrinde, and 
Maingay 2002). The majority of women and girls living with FGM/C suffer complications that require 
medical interventions to correct or mitigate the health risks.  
The health sector is strategically positioned to prevent FGM/C and manage related complications. 
The health sector–led FGM/C prevention should include: i) communicating risks and health 
consequences of the practice; and ii) supporting implementation of policies for the abandonment 
of FGM/C by communities and families including addressing medicalised FGM/C, and fulfilling the 
legal requirements for reporting cases of FGM/C to the law enforcement authorities. Similarly, the 
health sector should respond to women and girls who are living with FGM/C-related complications, 
spanning from immediate to long-term including psychological and sexual consequences (Kimani, 
Muteshi, and Njue 2016, Kimani et al. 2018).  
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Globally, there is increasing support for and commitment to tackling FGM/C through the 
development of legal and policy frameworks addressing the prevention and management of 
FGM/C. To date, 26 African and Middle Eastern nations as well as 33 countries with FGM/C-
practising migrant populations have adopted laws criminalising the practice (UNICEF, 2016). 
Additionally, to operationalise the health sector–led management and prevention of FGM/C, WHO 
developed supporting guidelines and tools in 2016 and 2018 (WHO 2016, 2018), respectively, for 
countries to adapt and adopt. 
To address the prevention and management of FGM/C in Kenya, various legal instruments have 
been developed and adopted. These are the Prohibition of Female Genital Mutilation Act of 2011 
(National Council for Law Reporting 2011); Children's Act of 2001 (HMSO 2004); Penal Code 
Chapter 63 (Republic of Kenya 2012b); and Protection Against Domestic Violence Act of 2015 
(Republic of Kenya 2015). These legal instruments also prohibit the medicalisation of FGM/C, 
which includes re-infibulation (re-suturing of the external genitalia to the infibulated state) at any 
point in time in a woman’s life following delivery, de-infibulation, and related gynaecological 
interventions. The Prohibition of Female Genital Mutilation Act spells out jail terms and penalties 
for the perpetrators and any parties who aid or abet the practice. The Act also requires anyone 
who is aware of the conduct of FGM/C on a woman or girl to report such incidents to law 
enforcement authorities. By implication, health providers are legally obliged to report fresh cases 
of FGM/C encountered in their course of duty, however there is weakness in the implementation 
of these provisions 
To operationalise the laws, the government has developed policies such as the Adolescent Sexual 
and Reproductive Health Policy of 2015 (MOH 2015), and the National School Health Policy of 
2009 revised in 2018 (Republic of Kenya 2018). Furthermore, plans of action and strategies have 
been developed in line with sector-specific policies to support the prevention and management of 
FGM/C in various settings.  
The laws, diverse policies, plans of action, and implementation strategies, as well as a reference 
manual for the management and prevention of FGM/C (Manual, 2007) should provide a perfect 
environment for the health sector to respond significantly with regard to FGM/C abandonment. 
However, the implementation of these comprehensive, well-intended documents has not been 
evaluated, with indications that the health sector may not have been able to implement them. 
Theoretical underpinnings 
To better understand the Kenyan health system’s response to FGM/C, we conducted a diagnostic 
assessment with the aim of identifying possible solutions for strengthening it. The study was 
anchored on Miller and colleagues’ situation analysis framework (Miller et al. 1997), and modelled 
around the systems thinking of the Primary Health Care Operations Research Project (PRICOR) 
(Center for Human Services 1998), Frerich’s Rapid Survey Methodology (Frerichs 1989; Frerichs 
and Khin Tar Tar 1989) as well as the quality of care framework as described by Bruce (Bruce 
1990). In addition, the study was anchored on the WHO health-systems framework (WHO 2007). 
The framework describes health systems in terms of six building blocks, namely: service delivery; 
health workforce; health information systems; access to essential medicines, vaccines, and 
technologies; financing; and leadership and governance. The approach helped assess the quality 
of care for the management of FGM/C-related complications by delving into current policy 
frameworks, programme standards, readiness of service delivery staff, and facilities, actual quality 
of service received, and impact of services on client satisfaction across service delivery points 
(SDPs) (Miller et al. 1997). 
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Objectives 
Broad objective 
To assess the health sector’s response to FGM/C management and prevention, with a view to 
identifying possible solutions for strengthening the sector’s contribution to the abandonment of 
FGM/C in Kenya. 
Specific objectives 
1. To examine how the healthcare sector supports prevention of FGM/C in line with country 
laws and policies; 
2. To determine the role of the healthcare sector in the management of FGM/C-related 
complications and the quality of care offered to clients; and 
3. To identify possible solutions for strengthening the healthcare sector towards management 
and prevention of FGM/C. 
Research questions 
This study sought to address the following key research questions: 
1. How is the health sector responding to existing FGM/C-related laws and policies? 
2. What role is the healthcare sector playing in the prevention of FGM/C? 
3. What are contextual factors supporting or inhibiting the health sector’s response to 
FGM/C?  
4. What are the availability, content, and quality of FGM/C-related service provisions? 
5. How is the health sector catering to the needs of women and girls who have undergone 
FGM/C?  
Methods 
Study design 
We conducted a mixed-method study involving qualitative and quantitative data collection at 
national, county (West Pokot County), and health-facility levels in Kenya. We conducted (1) key 
informant interviews (KIIs) with FGM/C policy actors at the national and county level; (2) focus 
group discussions (FGDs) with service providers and women with FGM/C; (3) in-depth interviews 
(IDIs) with service providers; (4) health facility assessments; (5) observations of client–provider 
interactions; (6) client exit interviews; and (7) service data abstraction (Table 1).  
The policy/standards relevant to the prevention and management of FGM/C-related complications 
were appraised through data collected from health facility assessments. Information obtained from 
the health facility assessment helped determine facility readiness to provide services to survivors 
of FGM/C-related complications. Staff readiness to provide FGM/C- related services were 
assessed through FGDs and IDIs with different cadres of health providers working at service 
delivery points that encountered women/girls who had experienced FGM/C-related complications. 
Information on the content and quality of FGM/C-related service delivery were obtained through 
observations of client–provider interactions, client exit interviews following client–provider 
interactions, and a review of FGM/C-related data in facility health records (service data 
abstraction). Data were analysed and information triangulated to create a valid picture of the health 
sector response to FGM/C.  
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Table 1. A summary of data-gathering activities and their corresponding sample size 
S/N Data-
gathering 
activity 
Study population Sample size Study location 
1 Key 
informant 
interview 
Representatives from the government 
(relevant ministries and parastatals), private 
organisations, NGOs, health development 
partners, health professional associations, 
health professional regulatory organisations, 
and training institutions 
34 National and 
county levels 
2 Focus group 
discussions  
Healthcare workers (nurses/midwives), 
women with FGM-related complications 
 
32 (Nurse-
midwives—3 groups 
of 8 participants, 
Women with FGM—1 
group of 8 
participants) 
County level 
3 In-depth 
interviews  
Healthcare workers (doctors, 
nurses/midwives, clinical officers) working at 
selected service delivery points 
23 (doctors—6, 
clinical officers—5, 
Nurse-Midwives—12) 
County-level 
health facilities 
4 Health facility 
assessment  
Health facility administrators of tertiary, 
secondary, primary, and private service 
delivery points  
30 County-level 
health facilities 
5 Observations 
of client–
provider 
interactions 
Healthcare providers and women with 
FGM/C-seeking reproductive health services 
61 County-level 
health facilities 
6 client exit 
interviews 
Women with FGM/C-seeking reproductive 
health services 
360 County-level 
health facilities 
7 Service data 
abstraction 
Health facility administers, healthcare 
providers 
10 County-level 
health facilities 
 
Study sites 
Interviews with legal and policy actors at the national level were conducted in Nairobi. All other 
data were collected in West Pokot county. The county is in the Rift Valley bordering the Republic 
of Uganda and covering an area of 9,169.39 KM2. In 2015, the county had an estimated population 
of about 600,000 people (49.7% male) (KDHS 2014). The county had 126 health facilities 
categorised into 87 public, three nongovernmental, 20 faith-based, and 16 private operated health 
facilities, respectively (KMHFL 2017). In 2013, the provider to population ratios were 67 nurses, 
five doctors, and 23 clinical officers per 100,000 people (Mapping Report 2013). Most women in 
the county deliver at home assisted by traditional birth attendants, with only 25.8% of births 
delivered at a health facility (KDHS 2014). The county has high maternal and infant mortality rates. 
The county is inhabited mainly by the Pokot people and other dominant Kalenjin communities. The 
Pokot community practises type III FGM/C with a high prevalence of 94%. There is no documented 
evidence of healthcare providers being involved in cutting girls in West Pokot. Girls are cut at an 
age of 12–15 years as a rite of passage to adulthood by traditional practitioners, and the shifts 
associated with FGM/C observed in other communities (Kimani and Kabiru 2018) have not been 
reported. Furthermore, cross-border dynamics associated with FGM/C are rife because the Pokot 
community members are also found in Uganda and share a porous border. Programmatically, 
West Pokot has been a target county for the UNFPA-UNICEF Joint Programme on FGM/C.  
Participants 
Study participants included national-level stakeholders/actors from Nairobi and West Pokot county 
stakeholders/actors involved in FGM/C-related law/policy processes such as representatives from 
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government (relevant ministries, departments, and agencies), health-related development 
partners, non-governmental organisations (NGOs), health professional regulatory organisations, 
health professional associations, training institutions, and community-based organisations. We 
also recruited healthcare providers including doctors, nurses/midwives, and clinical officers 
working in service delivery points who encountered and/or dealt with women/girls with FGM/C-
related complications (antenatal, postnatal, family planning, youth-friendly, delivery and newborn 
services; and accident and emergency departments in both public and private tertiary, secondary, 
primary, and private/faith based facilities). We also recruited girls (14–17 years) and women (18 
years and above) with FGM/C-related complications.  
Sampling and sample size  
Participants for the policy-relevant interviews were purposively selected to include those who had 
been involved in the policy processes of FGM/C-related laws, policies, and guidelines. Health 
providers were also purposively recruited to include a mix of providers who worked in service points 
that encounter girls and women who had undergone FGM/C and to represent a mix of providers 
working in tertiary, secondary, primary, and private health facilities across West Pokot county.  
The sample size for FGDs was informed by thematic saturation of data, and the size for those who 
participated in IDIs and KIIs was informed by representation across sectors and actors, thematic 
saturation, geographic locations, and categories of the health facilities. A total of four FGDs, 23 
IDIs, and 34 KIIs were conducted. We interviewed five clinical officers, six medical officers, and 11 
nurses or midwives. Table 2 summarises the demographic characteristics of participants in IDIs 
and KIIs. The majority (65%) were males and of Pokot ethnicity (49%). About a third (32%) of these 
participants were aged 21–30 years, 25% were aged 31–40 years and 40% were older than 40 
years. Fifty-three percent of the healthcare providers had worked at the health facility for over six 
years while 47% reported that they had worked in the facility for less than six years.  
Table 2. Demographic characteristics of participants in the in-depth interviews (IDIs) and key 
informant interviews (KIIs) 
Characteristics IDIs (N=23) KIIs (N=34) 
 (n) Percent (n) Percent 
Gender     
Male 14 60.9 23 67.7 
Female 9 39.1 11 32.3 
Ethnicity     
Pokot 9 39.1 19 55.9 
Other ethnicity 8 34.8 12 35.3 
Other Kalenjin group 4 17.4 1 2.9 
Missing 2 8.7 2 5.9 
Age (years)     
21–30 14 60.9 4 11.7 
31–40 2 8.7 12 35.3 
41 or older 6 26.1 17 50.0 
Missing 1 4.3 1 2.9 
Years at the facility/organisation     
0–5 years 17 73.9 10 29.4 
6+ years 6 26.1 24 70.6 
Section/department (IDI only)     
Clinical assessment room 1 4.3 - - 
Maternity 8 34.8 - - 
Obstetric 3 13.0 - - 
OPD 4 17.4 - - 
Theatre 4 17.4 - - 
Other 4 17.4 - - 
Cadre of the officer (IDI only)   - - 
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Characteristics IDIs (N=23) KIIs (N=34) 
 (n) Percent (n) Percent 
Clinical officer 5 21.7 - - 
Medical officer 6 26.1 - - 
Nurse/midwife 12 52.1 - - 
Organisation represented (KII only)     
Government - - 18 52.9 
Health development partners - - 3 8.8 
Health professional associations - - 4 11.8 
NGOs players in FGM/C - - 5 14.7 
Missing - - 4 11.8 
 
A multistage sampling was used to sample respondents and facilities for quantitative data. We 
clustered the facilities into different categories (tertiary, secondary, primary, and private/faith-
based) using a list of health facilities obtained from the county health office. We then sampled all 
facilities in sub-counties with a high prevalence of FGM/C. Clients were recruited for the exit 
interviews and observations of client–provider interactions as they sought services from health 
facilities in West Pokot. Eligible girls (14–17 years) and women (18 years and older) with FGM/C-
related complications were identified, recruited and consent obtained to participate in the exit 
interviews and client–provider interaction observations The clients who participated in the exit 
interviews and client–provider interaction were conveniently sampled after they met the inclusion 
criteria. A total of 360 exit interviews and 61 client–provider interactions were conducted. Table 3 
summarises the demographic characteristics of the exit interview respondents. Thirty-nine percent 
were aged 15–19 years while 38% were aged between 20 and 30 years. A majority (53%) were in 
a monogamous marriage. About half (52%) had 1–3 children. A third of the respondents (33%) 
had never attended formal schooling while 48% had primary-level education. About a quarter 
(26%) reported having no income at all, 17% earned less than 3,000 Kenyan Shillings (~30 US 
dollars), 16% between 3,000–5,000 Kenyan Shillings, 13% between 10,000–20,000 Kenyan 
Shillings while 7% earned more than 20,000 Kenyan Shillings. Most (76%) of the interviewed 
participants reported that they had undergone FGM/C when aged 11–15 years, with the procedure 
mainly (95%) performed by traditional circumcisers.   
Table 3. Demographic characteristics of participants during exit interviews (n=360) 
  
 Characteristics 
  
FACILITY LEVEL 
Primary 
N=220 
Secondary 
N=98 
Tertiary 
N=42 
Total 
N=360 
n % N % n % n % 
Age                 
<15 years 3 1.4 1 1 0 0 4 1.1 
15–19 years 95 43.2 33 33.7 12 28.6 140 38.9 
20–24 years 37 16.8 21 21.4 10 23.8 68 18.9 
25–30 years  35 15.9 18 18.4 13 31 66 18.3 
30 years or older 50 22.7 25 25.5 7 16.7 82 22.8 
Marital status         
Married/monogamous 100 45.5 61 62.2 31 73.8 192 53.3 
Married/polygamous 83 37.7 29 29.6 9 21.4 121 33.6 
Single, never married 30 13.6 5 5.1 2 4.8 37 10.3 
Divorced/separated/widowed 2 0.9 0 0 0 0 2 0.6 
Missing 5 2.3 3 3.1 0 0 8 2.2 
Number of living children         
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 Characteristics 
  
FACILITY LEVEL 
Primary 
N=220 
Secondary 
N=98 
Tertiary 
N=42 
Total 
N=360 
n % N % n % n % 
None 30 13.6 8 8.2 3 7.1 41 11.4 
1–3 children 108 49.1 50 51 29 69 187 51.9 
4–7 children 52 23.6 23 23.5 6 14.3 81 22.5 
7 or more children 26 11.8 11 11.2 3 7.1 40 11.1 
Missing 4 1.8 6 6.1 1 2.4 11 3.1 
Education level         
Did not attend formal school 73 33.2 35 35.7 11 26.2 119 33.1 
Primary 109 49.5 48 49 14 33.3 171 47.5 
Secondary 33 15 8 8.2 12 28.6 53 14.7 
Tertiary 3 1.4 6 6.1 5 11.9 14 3.9 
Missing 2 0.9 1 1 0 0 3 0.8 
Monthly income (Kenyan Shillings)         
None 31 28.4 9 17 10 35.7 50 26.3 
<3000 25 22.9 5 9.4 2 7.1 32 16.8 
3000 to <5000 20 18.3 9 17 1 3.6 30 15.8 
5000 to <10000 22 20.2 13 24.5 5 17.9 40 21.1 
10000 to <20000 8 7.3 9 17 7 25 24 12.6 
20000 or more 3 2.8 8 15.1 3 10.7 14 7.4 
Total 109 100 53 100 28 100 190 100 
Missing/don’t know 111 50.5 45 45.9 14 33.3 170 47.2 
Age of undergoing FGM         
8–10 years 9 4 8 9 3 7 20 5.6 
11–15 years 169 77 75 77 30 71 274 76.1 
16–19 years 38 17 15 15 8 19 61 16.9 
20 years and above 4 2 0 0 1 2 5 1.4 
 
The characteristics and distribution of facilities where client–provider interactions were observed 
are summarised in Table 4. The facilities were located in four sub-counties; Pokot Central (39.3%), 
Pokot South (24.6%), Pokot West (21.3%), and Pokot North (14.8%). The majority (92%) of the 
observations were conducted in primary-level health facilities—dispensaries and health centres.  
Table 4. Characteristics and distribution of health facilities in which client–provider 
interactions were observed (n=61) 
 Characteristics Frequency (n) Percent (%) 
Sub-county   
Pokot West  (13) 21.3 
Pokot Central  (24) 39.3 
Pokot North  (9) 14.8 
Pokot South (15) 24.6 
Total (61) 100 
Level of facility   
Primary (health centre and dispensary) (56) 91.80 
Secondary (sub-county hospital and 
mission led facilities) 
(4) 6.56 
Tertiary (county referral hospital) (1) 1.64 
Total (61) 100 
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A total of 30 facilities were identified and selected for the health facility assessments—3% tertiary, 
13% secondary, and 83% primary or faith-based facilities spread across the four sub-counties. 
Data abstractions were conducted in 10 facilities—one tertiary, two secondary, five primary, and 
two private facilities. 
Study instruments 
The KII guide focused on events that triggered agenda-setting on FGM/C, the input of different 
stakeholders in the implementation of health system FGM/C policies, and the process relating to 
FGM/C management and prevention strategies emanating from the policy. The FGD guide focused 
on eliciting responses on healthcare providers’ experience and training on FGM/C, knowledge of 
FGM/C prevention/management standards, attitudes towards FGM/C practise, and 
implementation of existing FGM/C policies, as well as FGM/C prevention/management practises 
including referral mechanisms and supervision. The guide for IDIs with healthcare providers 
addressed general attitudes and knowledge on FGM/C, management of FGM/C complications, 
prevention of FGM/C, supervisory mechanisms, and documentation of FGM/C. The validity of the 
guides was ensured through an extensive literature review to identify necessary questions as well 
as feedback received during exploratory meetings with stakeholders and during training sessions 
with research assistants. The discussions/interviews commenced with general statements 
followed with specific questions to elicit answers to the various thematic components regarding the 
health-sector responses to prevention and management of FGM/C-related complications.  
The health facility assessment and client–provider interactions checklists, client exit interviews 
questionnaire, and service data abstraction tool were adopted and modified from a handbook 
entitled “Assessing Integration Methodology.” There was a handbook for measuring and assessing 
the integration of family planning and other reproductive health services (Rivero-Fuentes et al. 
2008). The health facility assessment inventory was a 129-question tool comprising nine sections 
designed to garner information on facility operations; provision of services; availability of equipment 
and service commodities; availability of information, education, and communication materials and 
activities; supervision; availability of protocols and guidelines; referral system related to FGM/C; 
and staffing. The tool was interviewer-administered. The structured provider interaction was 
documented using a checklist. This helped document interactions between provider and client on 
services that included identification, management, and prevention of FGM/C.  
The exit interview questionnaires included socio-demographic information, and personal FGM/C 
Information—for example, whether the client had undergone FGM/C, including at what age, 
reasons why the clients visited the health facility—as well as whether the health provider discussed 
with them about FGM/C-related complications. Furthermore, the questionnaire had components 
on follow-up care and referrals, satisfaction with services, costs, and accessibility of the health 
services. The client exit interview questionnaire was translated into Kiswahili and local West Pokot 
languages.  
We conducted health facility data abstraction using a checklist. The checklist contained the 
following components: facility identification; information on service statistics, such as number of 
pregnant women attending ANC and number of pregnant women with FGM/C attending ANC. 
Other questions included: number of women/girls with FGM/C-related complications, number of 
women/girls who have undergone FGM/C and received counselling, etc, as well as the number of 
women/girls with FGM/C who received antibiotics and painkillers. The tools were pretested and 
validated during research-assistant trainings and feedback incorporated accordingly. 
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Recruitment and interview procedures 
The county-level governance participants were recruited after an exploratory visit to the county 
prior to the commencement of the study. The principal investigator and co-investigators met with 
the key stakeholders/actors to understand the county, the health system, and whether FGM/C was 
an important issue. During these meetings, the investigators explained the study objectives and 
sought a list of people/stakeholders who should be interviewed and participate in the study. The 
county and national governance stakeholders were contacted by phone or letter to inform them 
about the study and request their permission for the interview. Health providers were approached 
after obtaining permission to interview them from the Director of Health Services.  
We obtained written or verbal informed consent from all participants. For the KIIs, IDIs, and FGDs, 
we also obtained permission to audio record the interview or discussions. Participants were 
assured that all information provided would be treated with confidentiality and all the discussions 
and interviews were always conducted in private spaces that were convenient to the participants. 
The demographic characteristics for FGD participants were recorded on a self-completed 
participant record form. Except for the FGD with women living with FGM/C and the exit interviews 
which were conducted in the local dialect, all other FGDs, IDIs and KIIs conducted in West Pokot 
were done in English by trained, locally recruited research assistants. The KIIs conducted with 
national-level stakeholders were conducted in English by the study investigators. The discussion 
or interview started with general statements followed by specific questions as the participant got 
comfortable. The interviews lasted for about 45 minutes while FGDs lasted one and a half hours. 
The discussions were conducted by a moderator and a recorder in a quiet and private space with 
no interruptions. During the FGDs, the participants were seated in a circle, with sessions 
commencing with introductions, after which informed consent was obtained from each FGD 
member. The moderator commenced the discussion by presenting questions on general FGM/C 
issues, then delving into specific questions. The discussions were concluded by allowing 
contributions from every member until consensus was reached.  
Data analysis 
Quantitative data were coded and entered into Epi-data 3.1 on password-protected computers by 
trained data clerks and exported to STATA version 14.2 for data-quality assurance and cleaning. 
Cleaned data were then analysed using STATA version 14.2. Univariate and bivariate analyses 
were used to summarise the data with mean as a measure of central tendency and standard 
deviation as a measure of spread for continuous variables. Frequencies and proportions were 
reported for categorical variables. Some continuous variables were also categorised and 
presented as proportions. The data summaries are presented in the tables and graphs.  
Digital audio recordings for the group discussions/interviews were subjected to a multi-stage 
transcription process to ensure data quality. First, recordings were transcribed verbatim by 
experienced transcribers. Second, the anonymised transcripts were independently reviewed, 
checking the transcripts against the original audio recordings for accuracy, spelling, and content. 
Any differences detected between the two formats were identified, discussed, and resolved. The 
finalised versions were then subjected to qualitative analyses.  
The framework method for qualitative content analyses was adopted for this study (Ritchie et al. 
2013) The framework method is appropriate for thematic analysis of textual data, particularly 
interview transcripts, where it is important to compare data by themes across many cases (Gale 
et al. 2013). This approach combines deductive and inductive analyses of textual data with the 
flexibility to adapt emerging data and produce a coding framework or “template.” The 
themes/codes were selected through a combined approach: deductively based on previous 
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literature and the specifics of the research question from the interview guides, as well as inductively 
generated from the obtained data in the transcripts, followed by their refinement.  
Several team meetings between the investigators and qualitative research analysts were 
conducted to train the team members for a collaborative analysis and interpretation. The 
investigators and two research analysts developed a thematic coding framework through analysis 
of the study instruments and reading of the transcripts to reconcile and gain insights on emerging 
issues. The team reviewed the framework and definitions of each theme or code for consistency 
and understanding before commencement of coding using NVivo 11®. Data were first coded with 
descriptive labels, then categorised into “code families” based on identified patterns. Each analyst 
coded two transcripts to check the effectiveness of the coding framework that was used for the 
team discussion. The team then refined the final coding framework that was used in the 
subsequent analyses. The analysts were then assigned the remaining transcripts. The emerging 
themes during coding were addressed in regular weekly meetings until the process was complete. 
To ensure the methodological rigour and trustworthiness of the study data, and in addition to the 
use of researcher triangulation (using two data analysts) and method triangulation (using three 
different interview types [IDIs, KIIs, and FGDs]), inter-rater coding reliability was assessed by 
having analysts coding a random sample of two transcripts coded by another analyst. Differences 
in coding were compared, discussed, and integrated by consensus. The data generated from the 
different methods were triangulated to form the narrative of this report. 
Ethical considerations 
Ethical approval for the study was granted by the Population Council’s Institutional Review Board 
(Ref: 830; dated October 16, 2017) and AMREF Health Africa Ethics and Scientific Review 
Committee (Ref: AMREF-ESRC P463/2018; dated July 3, 2018). In addition, permission to carry 
out the study was granted by the National Commission for Science, Technology and Innovation 
(Ref: NACOSTI/P/18/79790/24356; dated August 18, 2018), the West Pokot County 
Commissioner and the County Director of Health Services. Study participants aged 18 years and 
older granted informed consent, while assent was obtained for participants younger than 18 years 
and consent granted by parent/guardian or husband or male partner. Participants were informed 
of and taken through the study protocol including the measures to ensure confidentiality of the 
information shared and their rights to withdraw from the study at any time. Interviews and 
discussions were audio recorded with permission from the participants.  
Results 
The findings from different data collection approaches are integrated, presented, and discussed 
through the lens of the WHO health systems framework, which entails six building blocks: 
leadership and governance; health information systems; financing; health workforce; service 
delivery; and availability of essential medicines, vaccines and technologies. 
Leadership and governance 
Leadership and governance entails laws and policy frameworks, coalition-building, regulation, and 
attention to system design and accountability. The establishment of laws and policies addressing 
FGM/C means that the practice has become an important agenda item for discussion at the policy 
decision-making–level. In addition, since FGM/C abandonment require multi-sectoral 
collaboration, crosstalk, networking, and community strategies are important.   
Knowledge about laws and policies regarding FGM/C 
Most national-level stakeholders were aware of the various laws and policies that addressed 
FGM/C. The laws identified were the Children’s Act of 2001, Prohibition of FGM Act of 2011, and 
Prohibition of Domestic Violence Act of 2015. Policies that were noted to address FGM/C included 
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the National Adolescent Sexual and Reproductive Health Policy and the National School Health 
Policy. Participants also highlighted the Constitution of Kenya that was noted to recognise women’s 
and girls’ sexual and reproductive health rights and protects citizens from violence, with FGM/C 
being recognised as a form of violence. In describing the laws and policies, participants noted that 
the Prohibition of FGM Act criminalised FGM/C by defining the offence, and prescribing 
punishments for violators and those abetting FGM/C, and for those found with tools for performing 
the procedure, including medicalisation:  
 “Overall, we have the Constitution of Kenya, which protects and guarantees every one of 
their rights against violence in FGM, FGM being one of them. Then at the Ministry, we have 
the Kenya health, gender, and equality policy, although in draft form. Kenya health, gender, 
and equality policy, it’s still a draft, where FGM is highlighted strongly, it’s a violation to 
women and girls.”  
    Representative of the National Ministry of Health, Nairobi 
“The Prohibition of FGM Act is very critical for FGM/C prevention as it outlaws FGM/C from 
being done in a health facility and by health providers.” 
 Representative of the Kenya Medical Practitioners and Dentists Council, Nairobi 
As illustrated in the following quote, some participants noted that the development of the 
Prohibition of FGM Act and the Prohibition of Domestic Violence Act was necessitated by 
weaknesses identified during the implementation of the Children’s Act of 2001. 
“The Children’s Act was the earliest to address FGM, but in most cases, community 
members used to wait until children were [older than] 18, then they would cut them.”  
Representative of a national NGO on women’s rights 
Some national-level participants narrated the history around the development and implementation 
of the laws and policies responding to FGM/C. As illustrated in the following quotation, some 
participants noted that several factors such as increasing awareness of the harmful health and 
social consequences of FGM/C had triggered the development of these laws and policies.  
“There were a lot of publications, especially by WHO on the harmful health consequences 
associated with FGM. I remember in one of the documentaries that was presented at the 
International Conference on Population and Development in 1994, people were shown 
what doctors were encountering following FGM on girls. That triggered a movement within 
the international community; UNICEF, UNFPA came together and intensified efforts to 
address FGM-related health consequences. And this is where now the UN declarations 
come in and joint statements and that’s why again, at this time, people felt like …we 
focused so much on the health consequences.”  
International NGO representative, Nairobi 
“The country realised that FGM was contributing negatively to so many issues around 
women empowerment including girls not reaching their full potential. This was contributing 
highly to girls not being empowered to be what they would want to become, and also was 
leading to very high maternal deaths, and contributing to high expenditure in the area of 
health management. We cannot realise the vision 2030 for Kenya or the SDGs 
[Sustainable Development Goals] if you don't deal with this FGM issue. So, the country 
had to really give FGM/C a priority. And that's why it had to have the law in place and also 
have a board in place to coordinate.”   
Anti-FGM Board representative, Nairobi 
Although county actors, more so those who worked in administration and the social sector, were 
knowledgeable of laws and policies that addressed FGM/C-related prevention and management, 
several county-based participants noted that they were unfamiliar with the content of these laws 
and policies. Some of the county-based stakeholders explained that their limited knowledge 
stemmed from their non-involvement in formulation of the laws and policies.  
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“2011 Prohibition of FGM Act yes, I don’t know about the actual word perfectly, I cannot 
quote, but I know it is the one that prohibits and imposes a jail term, or a fine or both of 
them at the time, yeah.”  
Education sector officer, West Pokot County 
“FGM is illegal in this country by law; as a health provider, we were not very much in the 
formulation of that law that disallowed FGM, but I know there is law and we use that law to 
dissuade because this is a community that circumcises the girls. That law has been used 
here to try and reduce that practise” 
Health officer, West Pokot County 
Medicalisation, though an emerging threat to FGM/C abandonment efforts, was reportedly not 
addressed in the policies. Additionally, a majority of participants felt that there was a lack of policies 
that addressed the management of FGM/C-related complications. 
“The de-medicalisation policy is just a statement, it’s not a detailed sort of document. 
Basically, it prohibits trained medical persons from carrying out FGM/C and particularly 
within institutions licensed to provide health care.”  
 Representative of the Kenya Medical Practitioners and Dentists Council, Nairobi 
“Most of the documents I've seen are fairly silent on management, because until recently 
it is when people started discussing about reconstructive surgeries, psychological and 
emotional management. So, most of the interventions previously have been targeted on 
either prohibiting or preventing.” 
 Representative of the Kenya Medical Practitioners and Dentists Board, Nairobi 
Exclusion of health sector–relevant context in legal instruments 
Although the actors included those from health sector involved in policymaking, participants did 
not make any reference to legal instruments that were relevant and specific to health-sector 
responses to FGM/C—including medicalisation such as the Nurses Act and the Medical and 
Dentist Practitioner Act. Indeed, the practice of FGM/C per se is not explicitly addressed by these 
laws. The practice is not identified as an offence under the Medical Practitioners and Dentists Act 
(revised 2012) (Republic of Kenya 2012a), but the Act under Article 20(1) states that disciplinary 
proceedings may be instituted against a medical practitioner who commits an offence under the 
Penal Code or engages in “any infamous or disgraceful conduct in a professional respect.” 
Similarly, the Nurses Act (revised 2012) (Republic of Kenya 2011) does not explicitly address 
FGM/C, but states that a nurse may be removed from the register if found guilty of misconduct by 
the Nursing Council of Kenya. Although these laws do not explicitly address FGM/C, they are 
applied, together with other national laws, while handling cases of omission and commission.  
Barriers to implementing FGM/C interventions at the county level 
Participants at the national and county levels highlighted several governance factors that limited 
implementation of FGM/C interventions at the county level. These included the lack of guidelines 
and strategies adapted for use at the county level; non-involvement of stakeholders from counties 
in the formulation of laws and policies, which was noted to lead to local resistance; lack of 
guidelines on the prevention and management of FGM/C; and the lack of supportive tools including 
information, education and communication (IEC) materials. These challenges are highlighted in 
the following quotes 
“We are just using the national guidelines and strategies; there is none that has been 
domesticated specifically for West Pokot.”  
      National Ministry of Health official, Nairobi 
“Mostly you find they have formulated top to bottom where a team is picked from the 
national government. And then you get a few guys to come who may not necessarily be in 
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touch in the ground they sit in a conference somewhere then now they make an attempt to 
disseminate. And by the time you come with a fully formed policy, people are resistant.” 
 Representative of the Kenya Medical Practitioners and Dentists Council, Nairobi 
"I don’t think we have really specific guidelines; we need to come up with some. But in 
management of FGM it is just managed medically and symptomatically, the way we 
manage any other problem like bleeding." 
Nurse tutor, West Pokot County 
 “At the community level, we don’t have guidelines on prevention of FGM activities. But in 
terms of proper implementation of health talks in the community they can do it but they 
don’t have even the IEC materials for prevention of FGM/C, and the key messages.”  
Public health officer, West Pokot County 
In response to these challenges, some participants underscored the importance of involving 
grassroots stakeholders for successful implementation of anti-FGM policies in Kenya. 
“I think the best model to adopt is to form caucuses at the grassroots with subsequent 
representation all the way to the national stage to articulate their issues. There are places 
which are hot spots for FGM, those few counties can be identified, and we start involving 
that. We do bottom up then we harmonise thoughts and come up with policies, which are 
actually acceptable to all the players.”  
Representative of the Kenya Medical Practitioners and Dentists Council, Nairobi 
Health information systems 
As noted by the WHO, “a well-functioning health information system ensures production, analysis, 
dissemination and use of reliable and timely information on health determinants, health system 
performance and health status” (WHO 2007). For example, maternal and child health departments 
keep data on the number of women and children who present for antenatal, postnatal, family 
planning, and immunisation services. These data can strengthen programming and policy, and 
inform the allocation of resources. 
Service data abstraction results showed that while records on reproductive health services offered 
at health facilities in West Pokot were available, providers did not document the number of women 
with FGM/C and/or complications stemming from the practice. Moreover, there were no specific 
data on women/girls who sought or received FGM/C-related interventions like counselling; de-
infibulation; clitoral reconstruction; antibiotics for infection; painkillers; and surgical interventions 
for keloids, cysts, or scarring (Table 5).  
Table 5. Number of clients who sought reproductive health services in service points that 
interfaced with girls/women with FGM/C in West Pokot County (n=10) 
  
Last 12 months Last 6 
months 
Last 1 
month 
Facilities 
with 
missing 
data 
Number of clients seen at service delivery points 39548 31693 4555 5 
Number of women/girls who attended antenatal care 
1st trimester 2663 1297 118 2 
2nd trimester 10981 5312 961 1 
Number of women/girls with FGM/C who attended antenatal care 
1st trimester - - - 10 
2nd trimester - - - 10 
3rd trimester - - - 10 
Number of women/girls who attended post-natal care  
after first week of delivery 2334 1277 219 5 
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Last 12 months Last 6 
months 
Last 1 
month 
Facilities 
with 
missing 
data 
after six weeks of delivery 26 11 2 6 
Number of women/girls with FGM/C who attended post-natal care  
after first week of delivery - - - 10 
after six weeks of delivery - 3 - 9 
Number of women/girls who attended family 
planning (FP) 
4406 2539 410 2 
Number of women/girls with FGM/C who attended 
FP  
- - - 10 
Number of women/girls with FGM/C who attended 
youth-friendly services 
- - - 10 
Number of women with type I FGM/C attending 
service delivery points (SDPs) 
- - - 10 
Number of women with type II FGM/C attending 
SDPs 
- - - 10 
Number of women with type III FGM/C attending 
SDPs 
- - - 10 
Number of women/girls with: 
Immediate FGM/C complications - - - 10 
Obstetric FGM/C complications - - - 10 
Gynaecological FGM/C complications - - - 10 
Sexual FGM/C complications - - - 10 
Psychological FGM/C complications - - - 10 
Number of women/girls who have undergone 
FGM/C related counselling - - - 10 
FGM/C related de-infibulation - - - 10 
FGM/C-related clitoral reconstruction - - - 10 
Number of women/girls with FGM/C who received  
Antibiotics for infection - - - 10 
Painkillers - - - 10 
Surgical Interventions for (keloids, cyst, scarring) - - - 10 
Referrals - - - 10 
 
A common theme in the interviews/discussions was that the health system rarely collected data on 
FGM/C cases including the complications. Reasons for the limited collection of FGM/C-related 
data included the low priority placed on the practise relative to other health issues such as HIV and 
malaria. The lack of data was viewed as a barrier to planning, programming, and resource 
allocation. 
“We don't capture the data on how many girls or women came into the health facility 
because of FGM or related deaths, what caused the death? I don't know whether if you go 
to those facilities to look for such kind of data you will get it ... So that brings in the medical 
board to come up with a way where they can capture all the data...”   
representative from an NGO dealing with legal issues for women 
“The issue of medical coding relevant to FGM/C is neglected. It will be very important for 
the Health Information Management System to capture complications related to FGM since 
currently they are not recorded. For example, it's through FGM that there will be prolonged 
labour. But this something is not captured within the health system or recorded in the health 
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system. The health system focus is more on those indicators such as how many people 
have malaria, how many have HIV and those other pressing issues, thus FGM issues are 
neglected. The health practitioners coming from communities who perceive FGM as a 
normal rite of passage for girls they don't see it as a form of violation”.  
UN organisation representative, Nairobi 
“All along we keep referring to the KDHS, and we all know it's like done every five years 
and not very specific to the needs of the health sector. They basically have data on 
prevalence, which is important. But in terms of the health sector, we don't know how many 
women are presenting with those complications. How many health workers have been 
trained on managing this specifically, trained for managing FGM and providing care, we do 
not have data on who is actually carrying out FGM. So, it's really difficult to justify policy 
change without evidence, that is why we have seen the need to collect that data, to advise 
policy change, and to advise on allocation of resources.” 
 Ministry of Health Representative, Nairobi 
In efforts to address the gap in data on FGM/C, a Ministry of Health representative noted that the 
Ministry was working to include FGM/C indicators in the Health Management Information System 
(HMIS) to facilitate the collection of FGM/C-related data at service delivery points interfacing with 
women/girls with FGM/C.  
“And of late for FGM, specifically FGM, we are in the process of ensuring that we have 
indicators in the Kenya indicator manual, the Ministry of Health indicator manual, which 
spells out and describes all the indicators that are used to collect data within the health 
sector. So, we're in the process of getting FGM indicators into that manual. So that now 
we can begin to collect health sector–specific data, which we haven't had all through.”  
Ministry of Health Representative, Nairobi 
Financing 
A good health financing system ensures that there are adequate financial resources to cater for 
health services and to ensure that people are protected against costly services (WHO 2007). 
Although the health system in West Pokot provided essential services, FGM/C-related 
management and prevention interventions faced some financial challenges. Most participants cited 
the lack of budget or resource allocation by the county government as a barrier to the 
implementation of FGM/C-related prevention in health facilities. Participants noted that a majority 
of the funding was provided by NGOs, but that this funding was inadequate, thus limiting the reach 
of interventions. 
“So how do we make sure that we also have a certain percentage, typically going to issues 
of policy implementation in FGM. The African Union, member states are required to budget 
for resources for ending FGM by 2030. And for me I think there should just be a budget 
specifically for FGM policy implementation before 2030.”  
National government officer, Nairobi  
“I think 100% of the resource usually come from the NGOs that were fighting against FGM 
and not the government.”  
Chairlady, women’s CBO, West Pokot 
 “The NGOs are only reaching a small percentage in the community, like here in West 
Pokot we have only three NGOs that are working to fight against FGM, but are not covering 
the whole county. The other parts are not accessible, but it would now be part of the county 
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government, so in that case I could say that the resources are not sufficient to reach the 
whole county.”  
County government development officer, West Pokot  
Health workforce 
A well-performing health workforce is responsive, productive, competent, and efficient (WHO 
2007). Participants noted that providers’ inadequate training on FGM/C was a hindrance to 
provision of quality services. They explained, for example, that few providers were trained on 
techniques such as de-infibulation.  
“There are these issues of like de-infibulation, though many staff have not been trained.  
We lack support for the training of staff who are actually working in the maternity but for 
the few that have been trained, when there is a serious case of FGM they can be able to 
perform that procedure and help the survivor.” 
          Public health nurse, West Pokot 
A representative from the national Ministry of Health in Nairobi, noted that a training manual was 
under development to build healthcare providers’ capacity to provide specific FGM/C-related 
interventions.  
“Previously, health workers will manage FGM cases, victims, like any other patient. That is 
really not something that we routinely follow up, but we are hoping with the training manual, 
they are able to identify and even document.” 
Results from the client–provider interactions showed that while a majority of primary (88%), 
secondary (82%), and all tertiary health facilities had the requisite equipment to address common 
ailments, most service providers had inadequate knowledge of FGM/C (Table 6). Capacity-building 
of healthcare providers was therefore noted to be an important strategy to implement FGM/C 
prevention interventions.  
“What is very important when it comes to the health workers is creating capacity for them 
to share messages on FGM/C-related complications with the community."  
Ministry of Health Representative, Nairobi 
Table 6. Availability of health facility infrastructural and human capacity to respond to FGM/C 
(n=61) 
 LEVEL OF FACILITY 
 Primary 
N=43 
Secondary 
N=11 
Tertiary 
N=7 
Total 
N=61 
 n % N % n % n % 
Infrastructure  
Uses private area for consultations 
No 5 11.6 2 18.2 0 0 7 11.5 
Yes 38 88.4 9 81.8 7 100 54 88.5 
Service provider with adequate knowledge of FGM/C 
No 27 62.8 2 18.2 4 57.1 33 54.1 
Yes 14 32.6 9 81.8 3 42.9 26 42.6 
Missing 2 4.7 0 0 0 0 2 3.3 
Availability of different service providers to help with FGM/C cases 
No 39 90.7 10 90.9 1 14.3 50 82 
Yes 2 4.7 1 9.1 6 85.7 9 14.8 
Missing 2 4.7 0 0 0 0 2 3.3 
Explains the existence of referral pathway for FGM/C cases to higher level of care 
No 17 39.5 4 36.4 0 0 21 34.4 
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 LEVEL OF FACILITY 
 Primary 
N=43 
Secondary 
N=11 
Tertiary 
N=7 
Total 
N=61 
 n % N % n % n % 
Yes 25 58.1 7 63.6 7 100 39 63.9 
Missing 1 2.3 0 0 0 0 1 1.6 
Describes associations between the health facility and legal authorities 
No 24 55.8 5 45.5 1 14.3 30 49.2 
Yes 18 41.9 6 54.5 6 85.7 30 49.2 
Missing 1 2.3 0 0 0 0 1 1.6 
Uses the necessary equipment needed for consultation  
No 9 20.9 3 27.3 0 0 12 19.7 
Yes 34 79.1 7 63.6 7 100 48 78.7 
Missing 0 0 1 9.1 0 0 1 1.6 
 
Service delivery 
The WHO framework defines good service as effective, safe, and quality health interventions that 
are delivered to those who need them with prudent use of resources (WHO 2007). There were two 
categories of services that were provided by the health system and FGM/C programme 
implementers—health facility–based services and community-based interventions.  
The health facilities offered HIV screening and testing (100%); antenatal care (100%); child growth 
monitoring and immunisation (100%); family planning (97%); gynaecological (97%); delivery 
(97%), and postpartum care (97%), essential newborn care (87%), screening for sexually 
transmitted infections (STIs) and treatment (80%), infertility consultation (43%), and (37%) 
HIV/AIDS treatment and care (37%). However, specific FGM/C-related interventions were only 
offered in 23% of all facilities (Table 7). 
Table 7. Reproductive health and FGM/C-related services sought by women across facilities in 
West Pokot County (n=30) 
  Primary  
N=25 
Secondary 
N=4 
Tertiary  
N=1 
Total  
N=30 
 n % n % n % n % 
Reproductive health services         
STI screening and treatment 19 76.0 4 100.0 1 100.0 24 80.0 
HIV screening, testing, and counselling 25 100.0 4 100.0 1 100.0 30 100.0 
HIV/AIDS treatment and care 6 24.0 4 100.0 1 100.0 11 36.7 
Family planning counselling 25 100.0 3 75.0 1 100.0 29 96.7 
Infertility consultation 10 40.0 2 50.0 1 100.0 13 43.3 
Gynaecological services 24 96.0 4 100.0 1 100.0 29 96.7 
Specific FGM/C management 4 16.0 3 75.0 0 0.0 7 23.3 
Antenatal care 25 100.0 4 100.0 1 100.0 30 100.0 
Delivery 24 96.0 4 100.0 1 100.0 29 96.7 
Postpartum care 24 96.0 4 100.0 1 100.0 29 96.7 
Essential newborn care 22 88.0 3 75.0 1 100.0 26 86.7 
Child growth monitoring and immunisation 25 100.0 4 100.0 1 100.0 30 100.0 
FGM/C-related complications  
Participants noted that patients with FGM/C presented with a wide range of complications. These 
complications included bleeding; birth complications such as obstructed labour and postpartum 
haemorrhage; infections; and long-term complications such as fistulas, scars, and keloids. 
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Participants noted that fistulas were associated with prolonged and/or obstructed labour as a result 
of the inelastic scar resulting from FGM/C as well as the pinhole passage for those who were 
infibulated. Women were also reported to develop scars on their external genitalia that were 
generally left untreated unless they were severe.  
Participants also noted that women living with FGM/C experienced sexual and psychological 
complications. As illustrated in the following quotes, the sexual complications included difficulty in 
penetration due to infibulation, painful intercourse, and the lack of sexual enjoyment. Psychological 
complications, on the other hand, included psychological trauma and stigma. 
“The one that underwent circumcision, because of narrowed vaginal canal, when she 
meets a man (sexual intercourse), there is a struggle until she developed tears.”  
Nurse/midwife, FGD 
“I have seen a lady with FGM/C who was divorced because of keloids because the 
husband could not enter, they could not make love, it was difficult because they were all 
over and they divorced.”  
Midwife, Sub-county Hospital 
 “When you have sexual intercourse with a man, there must be pain. These young girls 
cannot come in contact with a man for the first three days; they just try around the outside 
part (genitalia) until when it slides in. But then there is so much pain. After three days they 
meet once again. The pain is unbearable.”  
Woman with FGM/C, FGD 
 “I want to imagine the ladies are left with so much pain especially when the skin around 
the vagina [is] brought together haphazardly during the procedure thereafter the woman 
suffers a lot of painful sex and no enjoyment.” 
 Medical doctor, County referral hospital 
“Girls are at times forced to undergo that FGM, others are being taken away from school. 
The psychological trauma that these people undergo is because others are forced to 
against their will.”  
Healthcare provider, West Pokot County 
 “Also … stigmatisation, you know currently people don’t want FGM and if you find 
someone who has done FGM and people [are] talking about the bad effects, you will find 
that deep inside her, she will be feeling some form of stigmatisation.”  
        Nurse/midwife, Dispensary 
Management of FGM-related complications  
A summary of illustrative quotes describing how FGM/C-related complications were managed is 
provided in Table 8. As women in West Pokot traditionally undergo type III (infibulation) FGM/C, 
the management interventions for birth complications associated with FGM/C presenting with 
obstructed labour included episiotomies, de-infibulation, and caesarean sections. Although some 
participants noted that healthcare providers in West Pokot offered counselling to clients with 
FGM/C-related complications, the client–provider interaction results showed that healthcare 
providers failed to identify FGM/C during interactions with the clients. 
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Table 8. Illustrative quotes on the management of FGM/C-related complications 
Complication Management 
Birth complications “The possible complications are difficulties in giving birth and delivering the 
baby because of the FGM scar. This requires having to do episiotomies which 
would otherwise be unwarranted to allow for passage of the baby.” Medical 
doctor, West Pokot County 
“During delivery this mother with FGM/C who has difficulty in delivery, we 
usually assist [her] by performing some surgical intervention called episiotomy 
so that the birth canal can be roomy enough for the mother to deliver and that 
is repaired of course after the delivery of the baby.” Midwife, County referral 
hospital 
“Most ladies when they come during labour, they have obstructed labour and 
difficulty in delivery and that means delivery is a problem; most [of] them end 
up in a theatre for caesarean section.” Nurse/midwife County referral hospital 
Bleeding “Complication of FGM… includes bleeding which can even lead to death. The 
first thing we do is to arrest the bleeding through suturing, because with FGM 
they cut too deep or cut a vein or artery. Therefore, one has to manage the 
bleeding before you do anything else.” Nurse/midwife, Dispensary, West Pokot 
County 
“We assess the extent of blood loss, grouping and cross-matching before 
initiating the blood transfusion. Once the transfusion is done, we can recheck 
the haemoglobin level and keep monitoring the patient.” Clinical officer, County 
referral hospital, West Pokot 
Infections “It depends with the severity; if the patient has come who is so severe we 
normally admit, we give fluids, give IV antibiotics, and we clean if there is a 
wound. For the minor, the minor case, we clean and we give oral antibiotics 
and we make follow-ups at times; we tell them to report if there are any 
complications that arise....” Healthcare provider, West Pokot County 
Scarring “Severe scar may require reconstructive surgery and that sometimes is not 
done since the level of expertise down in this marginalised county is actually 
really poor, and I want to imagine these ladies are left with so much pain.” 
Clinical officer, Sub-county referral hospital 
 
In most primary (88%) and secondary (55%) facilities providers did not ask their clients about 
FGM/C. Only healthcare providers in three primary- and two secondary-level facilities asked their 
patients about the severity of FGM/C, while healthcare providers in four primary- and three 
secondary-level facilities asked their clients about possible effects of FGM/C (Table 9). None of 
the providers at the tertiary level enquired about patients’ FGM/C status nor the possible effects of 
having undergone FGM/C. Some of the qualitative interview results suggest that the lack of 
attention to FGM/C may have stemmed from the lack of guidelines around the management of 
FGM/C complications resulting in these complications being treated symptomatically. 
“Health workers will manage FGM cases, like any other patient, so that if they present with 
acute bleeding, then you manage the presenting symptoms. If they present with obstructed 
labour, then you manage the obstruction, but you're not very keen on what caused the 
obstruction.”  
      National government officer of health, Nairobi 
“Even if it’s something (FGM/C) which was done illegally, when it has reached our hands, 
we need to treat as a patient, as somebody vulnerable. Not to start to ask who told you to 
do that without discrimination. So, you treat/manage accordingly; for example, if its 
bleeding, infection you manage accordingly as signs and symptoms present to you.” 
     Reproductive health coordinator, West Pokot County 
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Table 9. Healthcare providers’ identification of FGM/C while interacting with clients (n=61) 
  
  
  
LEVEL OF FACILITY 
Primary 
N=43 
Secondary 
N=11 
Tertiary 
N=7 
Total 
N=61 
n % N % n % n % 
Ask whether client has been cut before         
No 38 88.4 6 54.5 7 100 51 83.6 
Yes 4 9.3 5 45.5 0 0 9 14.8 
Missing 1 2.3 0 0 0 0 1 1.6 
Ask about the severity of cut         
No 40 93 9 81.8 7 100 56 91.8 
Yes 3 7 2 18.2 0 0 5 8.2 
Ask about possible effects of FGM/C         
No 39 90.7 8 72.7 7 100 54 88.5 
Yes 4 9.3 3 27.3 0 0 7 11.5 
Explain how FGM/C might have undermined 
health physically and mentally 
        
No 41 95.3 8 72.7 7 100 56 91.8 
Yes 2 4.7 3 27.3 0 0 5 8.2 
 
Further, client exit interview data suggested that while most (99%) service providers explained 
about care interventions or provided treatment instructions to the clients with reproductive health 
problems other than FGM/C (89%), very few providers explained the negative consequences of 
FGM/C (16%) or discussed the need for clients to stop practising FGM/C (15%) (Table 10). 
Table 10. Client-reported counselling practises among clients who sought reproductive 
services across health facilities (n=360). 
Communication 
  
FACILITY LEVEL 
Primary  
N=220 
Secondary 
N=98 
Tertiary 
N=42 
Total 
N=360 
(n) % (n) % (n) % (n) % 
Did the provider explain to you what he/she is managing and why? 
No (16) 7.3 (11) 11.2 (5) 11.9 32 8.9 
Yes (204) 92.7 (86) 87.8 (37) 88.1 327 90.8 
Missing (0) 0 (1) 1 (0) 0 1 0.3 
Did the provider explain the treatment instructions? 
No 23 10.5 10 10.2 5 11.9 38 10.6 
Yes 196 89.1 88 89.8 37 88.1 321 89.2 
Missing 1 0.5 0 0 0 0 1 0.3 
Did the provider explain to you the negative consequences of FGM/C? 
No 180 81.8 83 85 39 93 302 84 
Yes 40 18.2 15 15 3 7.1 58 16 
Did the provider discuss with you the need to stop practicing FGM/C? 
No 181 82.3 84 85.7 39 92.9 304 84.4 
Yes 38 17.3 14 14.3 3 7.1 55 15.3 
Missing 1 0.5 0 0 0 0 1 0.3 
During your visit today, were you given any information on follow-up care? 
No 62 28 14 14.3 8 19 84 23.3 
Yes 158 72 84 85.7 34 81 276 76.7 
During your visit today, were you given an appointment for a follow-up visit? 
No 2 1.3 1 1.2 2 5.7 5 1.8 
Yes 157 99 84 98.8 33 94.3 274 98.2 
During your visit today, were you referred for any services? 
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Communication 
  
FACILITY LEVEL 
Primary  
N=220 
Secondary 
N=98 
Tertiary 
N=42 
Total 
N=360 
(n) % (n) % (n) % (n) % 
No 205 93.2 96 98 37 88.1 338 93.9 
Yes 8 3.6 1 1 3 7.1 12 3.3 
Missing 7 3.2 1 1 2 4.8 10 2.8 
 
As shown in Table 11, most providers in primary (86%), secondary (55%), and tertiary (71%) 
facilities failed to educate or advise clients on approaches for prevention of FGM/C for their 
daughters.  
Table 11. Interventions related to FGM/C prevention across health facilities in West Pokot 
(n=61) 
Interventions for FGM/C prevention 
LEVEL OF FACILITY 
Primary 
(N=43) 
Secondary 
(N=11) 
Tertiary 
(N=7) 
Total (N=61) 
n % n % n % n % 
Education and advice relating to the prevention of FGM/C 
No 37 86 6 54.5 5 71.4 48 78.7 
Yes 6 14 5 45.5 1 14.3 12 19.7 
Missing 0 0 0 0 1 14.3 1 1.6 
Availability of link to the authorities to report potential risk due to FGM/C 
No 30 69.8 7 63.6 3 42.9 40 65.6 
Yes 13 30.2 4 36.4 3 42.9 20 32.8 
Missing 0 0 0 0 1 14.3 1 1.6 
Existence of mechanism for follow-up 
No 31 72.1 10 90.9 2 28.6 43 70.5 
Yes 11 25.6 1 9.1 4 57.1 16 26.2 
Missing 1 2.3 0 0 1 14.3 2 3.3 
Provision of IEC-related materials to help with reinforcement of prevention 
No 43 100 8 72.7 6 85.7 57 93.4 
Yes 0 0 3 27.3 0 0 3 4.9 
Missing 0 0 0 0 1 14.3 1 1.6 
Existence of link with local community civil groups and gatekeepers to help 
No 26 60.5 4 36.4 3 42.9 33 54.1 
Yes 16 37.2 7 63.6 3 42.9 26 42.6 
Missing 1 2.3 0 0 1 14.3 2 3.3 
Possible outreaches to the community to help with prevention of FGM/C 
No 31 72.1 6 54.5 3 42.9 40 65.6 
Yes 11 25.6 5 45.5 3 42.9 19 31.1 
Missing 1 2.3 0 0 1 14.3 2 3.3 
 
Challenges faced by healthcare providers in the clinical management of FGM/C 
Participants noted that they faced several challenges when managing patients with FGM/C-related 
complications. These included a lack of essential lifesaving resources like blood banks that were 
critical for managing heavy bleeding, and the lack of guidelines on the management of FGM/C 
complications. Further, participants noted that many facilities lacked skilled providers, which 
resulted in patients being referred to higher-level facilities for treatment. These challenges are 
illustrated in the following quotes: 
“Mostly like here we don’t have a blood bank. So, if patients come with a lot of bleeding, 
we just refer them. We don’t have a blood bank so that that blood transfusion cannot be 
conducted.”  
Nurse/midwife, Sub-county hospital 
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“According to our facility we are still below average in terms of quality because currently 
we don’t have a gynaecologist and we have a deficit of doctors also so in terms of 
management of complications we are still below average. The shortage has affected such 
that we cannot handle conditions like fistulas” 
Nurse/midwife, FGD, Faith-based hospital 
“Most of the documents I've seen are fairly silent on management of FGM/C. It is until 
recently when people started discussing about reconstructive surgeries, psychological and 
emotional management. So, most of the interventions previously have been targeted on 
either prohibiting or preventing the practice.”  
Representative of the Kenya Medical Practitioners and Dentists Board, Nairobi 
“In the previous documents there is nothing that was talking about specifically FGM/C 
management, breaking it down for the health worker on how they're supposed to manage 
the specific complications.”  
National Ministry of Health officer, Nairobi 
Some healthcare providers expressed challenges in conducting de-infibulation as a result of 
inadequate knowledge and skills or resistance from the clients. Furthermore, some clients were 
reported to request re-infibulation after de-infibulation during the birthing process. 
 “We just try though we don’t have enough knowledge on how to manage the 
complications, but one tries whatever [one] can. But I feel we need to have some, or more 
knowledge on how to perform de-infibulation because it is not easy to assist the woman 
whose episiotomy is already done at home.” 
Nurse/midwife, Sub-county hospital 
“There are some women we encounter, and we want to de-infibulate and they say no, don’t 
do it blah blah. So, you know it’s hard for one to deliver so we told them it’s hard for you to 
deliver if you can’t de-infibulate, so we have to do it.” 
Medical Doctor, County referral hospital 
 “So, the women request please after delivery, you can close it, so sometimes it’s as per 
the women’s request. If they insist, they want it closed, we just close. Yes, most of the time 
it is as for their request, there is nothing much I can do if she says so. Because even if you 
say you will leave it open and the woman decides to close. They will always look for 
somewhere to close it {laughter}. Yeah, they will always get out of the ward.” 
Clinical officer, County referral hospital 
“Then you know it’s traditional, because in this marriage, may be the husband may not be 
okay with the genitalia being open. The woman could be left (divorced) or the husband 
remarries another woman.”  
Nurse/midwife, Sub-county hospital 
Referrals 
In instances where providers were unable to provide care for FGM/C-related complications, 
patients were referred to higher-level facilities for management.  
“We do refer and link with [the] county referral hospital … if we can’t manage it, we refer to 
them. Most of the time we handle the normal delivery procedures, the abnormal we don’t.” 
Nurse/midwife, health centre  
“The woman has prolonged labour ... because there is no way this baby can come out. 
FGM/C obstructs the baby from coming out and the woman labours for [a] long time. Most 
of the women coming from our peripheries, health facilities or communities come with 
prolonged and obstructed labour. So, by time they reach the county hospital, they are 
helped to deliver through caesarean section.”  
Midwife, West Pokot county hospital 
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As shown in shown Table 12, referral systems to higher-level facilities existed in all primary, 
tertiary, and in some (25%) secondary facilities. FGM/C-related referrals were found in 63% of all 
facilities. The nature of the referrals for FGM/C cases was for birth (48%), gynaecological issues 
(32%), and immediate (11%) complications. Additionally, the client–provider interactions data 
showed that there were referral pathways for FGM/C cases. 
Table 12. Referrals for clients with various reproductive health problems (n=30) 
  Primary Secondary Tertiary Total 
  n % N % N % n % 
Existence of referral system to higher-level facilities 25 100.0 4 100.0 1 100.0 30 100.0 
Average number of referrals done per week                 
Rare 1 4.0 0 0.0 0 0.0 1 3.3 
1 14 56.0 0 0.0 0 0.0 14 46.7 
2 5 20.0 0 0.0 0 0.0 5 16.7 
3 to 7 2 8.0 4 100.0 0 0.0 6 20.0 
Missing 3 12.0 0 0.0 1 100.0 4 13.3 
Availability of tools/documents used for referral                 
No 1 4.0 0 0.0 0 0.0 1 3.3 
Yes 23 92.0 4 100.0 1 100.0 28 93.3 
Missing 1 4.0 0 0.0 0 0.0 1 3.3 
Services clients referred for (Yes=n):                 
FGM/C 15 60.0 3 75.0 1 100.0 19 63.3 
STI 8 32.0 1 25.0 0 0.0 9 30.0 
HIV/AIDS 19 76.0 2 50.0 0 0.0 21 70.0 
Family planning 8 32.0 3 75.0 0 0.0 11 36.7 
Antenatal care 12 48.0 3 75.0 1 100.0 16 53.3 
Postpartum care 10 40.0 2 50.0 0 0.0 12 40.0 
Essential newborn care 10 40.0 2 50.0 0 0.0 12 40.0 
Child immunisation 1 4.0 0 0.0 0 0.0 1 3.3 
Others 5 20.0 1 25.0 0 0.0 6 20.0 
Nature of referred FGM/C cases                 
Birth complications 8 53.3 1 33.3 0 0.0 9 47.4 
Gynaecological complications 4 26.7 1 33.3 1 100.0 6 31.6 
Immediate complications 2 13.3 0 0.0 0 0.0 2 10.5 
Missing 1 6.7 1 33.3 0 0.0 2 10.5 
Feedback after referral                 
No 18 72.0 2 50.0 1 100.0 21 70.0 
Yes 7 28.0 2 50.0 0 0.0 9 30.0 
 
Community-based services 
The health facility assessment showed that health talks were offered in some facilities, and the 
platforms for these talks were antenatal (57%) and postnatal (37%) assemblies for clients. The 
topics covered during the talks included HIV/AIDS, family planning, nutrition, pregnancy/labour and 
delivery, newborn care, and immunisation. Only 23% of the health facilities discussed FGM/C 
during the health talks (Table 13).  
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Table 13. FGM-related health talks conducted at service points within the health facilities 
  Primary Secondary Tertiary Total 
  n % n % n % n % 
Frequency of health talk per week                 
None 1 4.0 0 0.0 0 0.0 1 3.3 
Once 9 36.0 1 25.0 0 0.0 10 33.3 
Twice 4 16.0 1 25.0 0 0.0 5 16.7 
3–4 times 0 0.0 0 0.0 0 0.0 0 0.0 
5 times 8 32.0 0 0.0 0 0.0 8 26.7 
Daily 2 8.0 1 25.0 0 0.0 3 10.0 
Missing 1 4.0 1 25.0 1 100.0 3 10.0 
Platform of health talk                 
Antenatal gathering 14 56.0 2 50.0 1 100.0 17 56.7 
Postnatal gathering 9 36.0 2 50.0 0 0.0 11 36.7 
Part of youth-friendly services 1 4.0 0 0.0 0 0.0 1 3.3 
Others 17 68.0 3 75.0 0 0.0 20 66.7 
Topics covered                 
FGM/C 6 24.0 1 25.0 0 0.0 7 23.3 
STI 16 64.0 4 100.0 1 100.0 21 70.0 
HIV/AIDS 22 88.0 4 100.0 1 100.0 27 90.0 
Family planning 22 88.0 4 100.0 1 100.0 27 90.0 
Nutrition 21 84.0 4 100.0 1 100.0 26 86.7 
Pregnancy/labour and delivery 21 84.0 4 100.0 1 100.0 26 86.7 
Newborn care 19 76.0 4 100.0 1 100.0 24 80.0 
Immunisation 21 84.0 4 100.0 1 100.0 26 86.7 
Others 3 12.0 1 25.0 0 0.0 4 13.3 
 
A children’s officer in West Pokot noted that there were no FGM/C-specific outreach programmes 
saying:  
“You know for health sector they do outreaches on maybe immunisation, and nutrition teaching 
people on how to get good and well-balanced nutritive food, also prevention of maybe cholera, 
yeah those issues, but they will never have a specific outreach on FGM to talk about FGM/C.”  
However, some participants noted that healthcare providers participate in various community-
based and facility-based activities aimed at increasing awareness of FGM/C. These interventions 
included school health talks, community outreach programmes, community health volunteer 
(CHV)–led sensitisation, and radio talks. Reliance on CHVs in part stemmed from challenges in 
funding and the potential of CHVs to reach a wider network. Participants also noted the need for 
providers to leverage other ongoing outreach programmes addressing critical problems in the 
county. A summary of illustrative quotes describing these activities is provided in Table 14. 
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Table 14. Illustrative quotes citing various community- and facility-based FGM/C awareness 
activities conducted in West Pokot County 
Activity Illustrative quotes 
School health talks “The strategy that we have actually included is that of creating awareness at the 
county level and even at the facility level. Educating schoolchildren for example, 
during school health programmes, sometimes we go for school health 
programmes and we talk to the girls and the boys on issues of FGM.” Public health 
nurse, West Pokot County 
Community outreach “We also have the community outreaches, outreach advocating against the FGM 
basically, talking of these FGM practises, they should be against the FGM 
activities.” Health administrator, West Pokot County 
Facility-based FGM/C 
health talks 
“In terms of advocacy, it has been done very well and people have a lot of 
information about FGM and its effects. Many of our health workers engage with 
community members in health talks, especially for women when they come for 
antenatal, postnatal, and immunisation services.” Medical doctor, West Pokot 
County Hospital 
“What healthcare providers do is to provide information against FGM, it’s 
consequences, for example it leads to death, haemorrhage, and so forth, and 
should not be performed. Health facilities provide health education, sensitisation 
and awareness on FGM. They are given information on what they should do as far 
as FGM is concerned, disadvantages of FGM, why FGM should not be entertained 
in our communities. In case of those who have undergone FGM they are treated 
at the facility.” Health official, West Pokot County 
Community health 
volunteer-led sensitisation 
“We also have community engagement though in the few areas that have 
community volunteers, the community strategy system, and we also use them to 
pass the FGM/C messages. … Because of lack of funds, it can hinder the 
effectiveness of addressing FGM/C… We are now doing a lot of outreach and 
encouraging mothers to come to the hospital, we are giving them tokens if they 
come to deliver in the hospitals. … CHVs in every village are really advocating that 
mothers come and deliver at the hospitals.” Manager, West Pokot County referral 
hospital 
Radio talks “We use radio a lot to raise awareness and engage the community on matters 
FGM and the need for its abandonment. In these sessions the healthcare providers 
clarify why FGM is harmful, especially healthwise, as well as its compromises on 
the rights of women and girls.” Senior county health official, West Pokot  
  
Supervision of health facilities and availability of protocols and guidelines 
Table 15 summarises results on supervision from the health facility assessments. Sixteen facilities 
had supervisory visits within the five weeks preceding the assessment. During the visits, the 
supervisors observed the delivery of different services (100%), inquired about service problems 
(90%), examined records (93%), and made suggestions for improvement (93%). Most health 
facilities had general protocols and guidelines, which were used in 83% of facilities, but none had 
any protocol on FGM/C. There was a review of written guidelines and protocols for delivering 
reproductive health services in the last five years in two-thirds of the facilities (67%).
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Table 15. Health facility supervision and availability of FGM/C-related prevention 
protocols/resources (n=30) 
 Primary Secondary Tertiary Total 
 n % n % N % n % 
Last supervisory visit to the facility                 
<3 weeks 9 36.0 2 50.0 0 0.0 11 36.7 
3–5 weeks 5 20.0 0 0.0 0 0.0 5 16.7 
6–21 weeks 11 44.0 2 50.0 1 100.0 14 46.7 
What the supervisor did                 
Observed delivery of different services 25 100.0 4 100.0 1 100.0 30 100.0 
Observed only service(s) respondent is 
responsible for 
10 40.0 2 50.0 0 0.0 12 40.0 
Inquired about service problems 22 88.0 4 100.0 1 100.0 27 90.0 
Examined the records 23 92.0 4 100.0 1 100.0 28 93.3 
Made suggestions for improvement 23 92.0 4 100.0 1 100.0 28 93.3 
Other 10 40.0 0 0.0 1 100.0 11 36.7 
Availability of protocols and guidelines 21 84 4 100 1 100 26 86.7 
Protocols on FGM/C 0 0.0 0 0.0 0 0.0 0 0.0 
Use of protocols and guidelines 20 80 4 100 1 100 25 83.3 
Review of written guidelines and protocols 
for delivering reproductive health services 
in the last five years 
18 72 1 25 1 100 20 66.7 
Discussion  
The Kenyan health sector draws its mandate of responding to FGM/C prevention and management 
from the constitution, various enacted legal and policy frameworks, as well as best global practises. 
First, the 2010 Constitution of Kenya (Republic of Kenya 2010) contains clauses that protect 
women and girls from undergoing harmful practices including FGM/C. Specifically, Article 29(c) 
provides the right not to subject anyone “to any form of violence” or (f) “treated or punished in a 
cruel, inhuman or degrading manner,” while Article 44(3) bars any person from compelling another 
person to perform, observe, or undergo any cultural practice or rite, thus protecting adults from 
FGM/C. Similarly, children are protected from undergoing FGM/C in Article 53(d), which provides 
that any child should not be subjected to abuse, neglect, harmful cultural practices, all forms of 
violence, inhuman treatment, and punishment. Second, several specific laws address FGM/C 
including: The Children’s Act of 2001, Prohibition of FGM Act of 2011, and Protection Against 
Domestic Violence Act of 2015. The laws have been aligned to the Constitution as well as 
provisions from the international and regional legal/human rights instruments that address 
women’s/children’s rights, for which Kenya is a signatory.  
We found differences between national and county representatives’ awareness of FGM/C-related 
laws and policies, with the latter being less aware of relevant laws and policies. This finding 
suggests that the law and policymaking process may exclude critical stakeholders including 
providers and other actors at the county level, with possible implications for the implementation of 
the laws and policies. This calls for wider engagement of stakeholders when developing and 
reviewing legal frameworks, as non-involvement may negatively affect the implementation of these 
laws and policies.   
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Policy actors interviewed in this study noted that there are few health-related policies on FGM/C 
prevention and management. This is despite Kenya, through the Ministry of Health, having 
developed a reference manual for the management of FGM/C-related complications during 
pregnancy, childbirth, and the postpartum period in 2007 (MOH 2007). This finding suggests that 
there is inadequate dissemination of relevant policies within the health sector, which may result in 
FGM/C receiving less attention than other health issues. Furthermore, a disconnect in the policy 
formulation and dissemination process was noted. These findings are consistent with a desk 
review report that highlighted the need for the health sector to operationalise the legal/policy 
frameworks from high-level governance into plans of action/strategies as well as guidelines that 
are usable at the operational level (Otibho and Kimani 2019).  
The findings further demonstrate how the absence of a complete policy-process cycle spanning 
from formulation to dissemination and implementation resulted in a disconnect in the health 
sector’s response in West Pokot, where implementation of FGM/C prevention reportedly faced 
challenges because of inadequate knowledge about national FGM/C-related laws and policies. At 
the operational level, the response was hindered by the lack of tools, notably FGM/C guidelines, 
protocols and IEC materials to support FGM/C prevention and management. This finding suggests 
that FGM/C is not considered a priority for the health sector.  
Despite the prevalence of FGM/C being almost universal in West Pokot, the findings revealed that 
the county health sector lacked data capture or documentation for FGM/C-related cases and 
complications. While the qualitative results suggested women and girls presented with immediate 
FGM/C-related complications including bleeding and infections, service data abstraction from 
antenatal, postnatal, family planning, and youth-friendly care services pointed to a lack of records 
on women and girls with these complications. Specifically, we did not find records of FGM/C-related 
immediate, obstetric, gynaecological, sexual and psychological complications in health facilities. 
This is despite the availability of comprehensive data on women who sought other reproductive 
health services. The lack of FGM/C data may be attributed to poor operationalisation of health 
sector–related policies relevant to prevention and management of FGM/C as well as the lack of 
documentation tools for the operational level. The lack of data may also stem from  healthcare 
providers’ limited capacity to identify, manage, and document FGM/C-related cases (Kimani et al. 
2018). Consequently, FGM/C indicators are excluded from the HMIS, which limits the availability 
of evidence to inform programming and investments to address FGM/C. These findings underscore 
the need for interventions to strengthen healthcare providers’ knowledge and skills on identifying, 
managing, and documenting FGM/C cases, as well as the need to include FGM/C indicators in the 
HMIS.  
Regarding health service delivery readiness in West Pokot, results suggest that the health sector 
leverages school health, community outreach, community volunteer–led and vernacular radio to 
boost FGM/C awareness in the community. However, results from client–provider interactions 
showed that FGM/C-related prevention interventions in health facilities were rare with no 
individualised education or advice on FGM/C shared with clients. The limited attention to FGM/C 
may stem from healthcare providers’ limited knowledge about FGM/C as well as the low priority 
placed on the issue by the health sector  (Kimani, Muteshi, and Njue 2016; Kimani et al. 2018). 
Our findings underscore the need to strengthen the delivery of services targeted to women with 
FGM/C. Given funding constraints, the delivery of FGM/C services may be nested in existing 
programmes. For example, during our initial preparatory visits to the field we learned that the West 
Pokot health system is motivating pregnant women to deliver in health facilities through a 
residential programme for expectant women from hard-to-reach areas. The programme enables 
women at risk for complications to remain close to the hospital for two weeks to one month until 
delivery. This programme was noted to promote skilled birthing and to prevent FGM/C among 
women who may have escaped the cut as girls but would be cut by the traditional birth attendants 
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during delivery.   Leveraging such a programme to reach women and girls with FGM/C information 
and services may yield positive results. 
With respect to the health workforce, our findings highlighted healthcare providers’ limited capacity 
to effectively manage FGM/C-related complications. The client-provider interactions showed that 
90% of primary and secondary health facilities had providers who lacked the capacity to manage 
FGM/C complications. These findings point to possible gaps in professional training, inadequacy 
of the training curriculum to address FGM/C, and lack of continuous professional development 
modules addressing FGM/C-related complications. It is also an indication of neglect of this 
important issue within the health sector. This is consistent with recent findings among Somali 
women in Kenya with FGM/C who reported that they were attended to by providers who displayed 
some capacity challenges (Kimani et al. 2020). Providers’ limited capacity has significant 
implications for the quality of care received by women and girls living with FGM/C (Evans et al. 
2017; Hodes and Creighton 2017; WHO 2016; Zurynski et al. 2015) and can limit heath-seeking 
(Lazar et al. Shipp, 2013) For example, although best practise guidelines prescribe de-infibulation 
instead of episiotomy for women with obstructed labour associated with a type-III FGM/C scar  
(Kimani, Muteshi, and Njue 2016; WHO 2018), our results suggest that providers opt for 
episiotomies and caesarean sections because they lack training on de-infibulation. Other studies 
have also highlighted inadequate training of health providers on how to provide care and treatment 
to women/girls with FGM/C as a critical shortcoming ( Abdulcadir, Rodriguez, and Say 2015; 
Abdulcadir, Say, and Pallitto 2017; Kimani et al. 2018; Ormrod 2019;  Balfour et al. 2016). These 
findings underscore the need for capacity-building programmes for healthcare providers to 
enhance the health sector’s response to FGM/C, particularly in high-prevalence settings. In 
addition, providers should have access to support tools (Zenner et al. 2013) for management of 
FGM/C-related complications as well as prevention of FGM/C (Doucet, Pallitto, and Groleau 2017; 
Kimani, Muteshi, and Njue 2016; Rouzi and Alturki 2015). These tools can be useful in addressing 
gaps in knowledge and skills among healthcare providers.  
Findings suggest that women with FGM/C presented with sexual complications including difficulty 
in penetration, painful intercourse, and lack of enjoyment, as well as psychological consequences 
evidenced by psycho-trauma and stigmatisation. Surprisingly, however, there was no evidence on 
what interventions were implemented to address these complications. The findings are consistent 
with reports that most healthcare providers have challenges in identifying and addressing sexual 
and psychological complications (Hess, Weinland, and Saalinger 2010; Kimani et al. 2018; 
Widmark, Tishelman, and Ahlberg 2002; Zaidi et al. 2007). These results underscore the need for 
FGM/C-related interventions to address sexual and psychological complications (Horowitz and 
Jackson 1997; Johnsdotter and Essén 2016).  
An important aspect of service delivery is a well-functioning referral system (WHO 2007). The 
results of the health facility assessment showed very high levels of referrals between primary- and 
tertiary-level facilities, particularly for birth-related, gynaecological, and immediate complications.  
The referrals mainly stemmed from healthcare providers’ limited capacity to handle complications 
and from infrastructural limitations. The lack of a documentation and audit system for FGM/C-
related referrals suggests that the health system may not meet the norm of availability, accessibility 
as well as flexibility of response to FGM/C in high-prevalence settings where adverse outcomes 
related to the practice are commonplace (Berg, Denison, and Fretheim 2010). Notably, lack of a 
well-functioning referral system (Mujasi, Asbu, and Puig-Junoy 2016) has been attributed to an 
effect on the quality of care for women with reproductive health challenges (Moxey and Jones, 
2016) and trust in the healthcare system (Mbanya et al. 2018). Efforts to strengthen the referral 
system are therefore warranted. 
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Limitations 
The study has some limitations; first, healthcare providers who participated in the study might have 
thought that their general capability to perform their professional work was being assessed and 
thus presented a more positive picture of their experiences. Nonetheless, we expect that the 
triangulation of data across qualitative and quantitatively derived results helped to resolve any bias. 
Second, data on the health system were collected in one setting thus the generalisability of the 
findings is limited. However, this study adopted a robust approach to investigate the health-system 
response to FGM/C in terms of prevention and management. Therefore, the data provide a strong 
foundation for understanding the health system’s response FGM/C prevention and management 
in high-prevalence settings and lays a strong foundation for relevant policy, programming, and 
investment interventions with the health sector.   
Conclusion  
Although the Kenyan health sector’s response to FGM/C prevention and the management of 
women and girls with practice-related complications is anchored in robust legal and policy 
instruments, the study findings highlight several gaps that may have significant implications for the 
quality of care received by women and girls who are living with FGM/C, and for the health sector’s 
capacity to contribute to efforts to promote the abandonment of the practice. First, findings show 
that although the legal and policy instruments guiding the FGM/C response are well understood at 
high level governance, providers and other actors at the local level have limited awareness. 
Second, the health system lacks appropriate systems to capture data on FGM/C-related cases 
and complications, which limits the availability of evidence to inform policy, programming and 
investment decisions. Third, implementation of FGM/C interventions is limited by the lack of 
material, human, and financial resources. For example, healthcare providers lack the capacity to 
effectively manage many FGM/C-related complications with some, like sexual and psychological 
complications, being neglected. Taken together, these findings underscore the need to strengthen 
the health sector’s capacity to respond to prevent and manage FGM/C. 
Implications for Policy/Programmes/Research 
The study findings highlight several possible avenues for leveraging positive change: 
• Stakeholders in different levels of the health systems should be sensitised about laws and 
policies that address FGM/C prevention and management. 
• Tools to guide and support FGM/C-related prevention and management interventions should 
be developed.  
• Healthcare providers should be adequately trained to respond to women and girls with FGM/C-
related complications including birth, and sexual and psychological complications. 
• Systems to collect and document data on FGM/C in health facilities should be developed for 
use in policy, programming, and investment decision-making. 
• The referral system for FGM/C-related complications should be strengthened. 
• The health system should be adequately integrated and financed to respond to prevention and 
management of FGM/C. 
• A cost-utility analysis to examine the financial implications of integration of FGM/C 
interventions into the health services is needed. 
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